NASDAQ:SANA | Free Cash Flow | Sana Biotechnology, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$37.38M$288,000.00-$37.67M
2025-12-31-$32.64M$873,000.00-$33.51M
2025-03-31-$48.66M$136,000.00-$48.79M
2024-12-31-$47.16M$436,000.00-$47.6M
2024-03-31-$65.63M$15.85M-$81.48M
2023-12-31-$51.96M$14.05M-$66.01M
2023-03-31-$79.27M$2.18M-$81.45M
2022-12-31-$76.07M$4.6M-$80.67M
2022-03-31-$77.71M$7.53M-$85.24M
2021-12-31-$110.1M$5.2M-$115.3M
2021-03-31-$49.91M$6.44M-$56.35M
2020-12-31-$37.56M$9.27M-$46.83M
2020-03-31-$29.55M$5.6M-$35.15M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$143.83M$938,000.00-$144.77M
2024-12-31-$223.15M$33.43M-$256.58M
2023-12-31-$253.58M$20.03M-$273.61M
2022-12-31-$290.05M$20.88M-$310.93M
2021-12-31-$251.05M$29.86M-$280.92M
2020-12-31-$137.98M$23.87M-$161.85M
2019-12-31-$85.52M$26.12M-$111.64M